Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Ind-Swift Laboratories has agreed to sell its Active Pharmaceuticals Ingredients (API) business to PI Industries on a slump sale basis, both the companies said in exchange notifications.
“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides opportunities to collaborate with some of the best scientists in the world by working out of the campus,” said CEO and managing director Jonathan Hunt.
The subject expert committee (SEC) under India's drug regulator gave its go-ahead to Hyderabad-based Bharat Biotech to conduct the phase 2/3 clinical trials, administering a dose each of Covaxin and the adenoviral intranasal vaccine with an interval between the two.
Fulvestrant injection is used alone or in combination with other drugs to treat a certain type of hormone receptor positive, advanced breast cancer (breast cancer that depends on hormones such as estrogen to grow) or breast cancer that has spread to other parts of the body in women who have experienced menopause.
Rapid vaccination is key to preventing a devastating third wave. However, states such as Kerala and some in the Northeast may also need to impose two-three weeks of hard lockdown to control the resurgence. A look at the situation as the month draws to a close.
Generic Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquire 100 per cent of the shares of Southern Cross Pharma Pty Ltd (SCP), Lupin said in a regulatory filing.
If you are 18 or older and have not been vaccinated yet, you may be asking whether getting an AstraZeneca vaccine right now is the right thing for you to do. To answer this we need to consider the benefits and risks of the AstraZeneca vaccination.
The agency’s new masking guidelines for vaccinated people, introduced Tuesday, were based on the information presented in the document. The CDC recommended that vaccinated people wear masks indoors in public settings in communities with high transmission of the virus.
The latest guidance from the U.S. Centers for Disease Control and Prevention says people who are fully vaccinated should get tested three to five days after a potential exposure, even if they don't have symptoms.
The US Food and Drug Administration (USFDA) had conducted a remote and virtual bio-analytical inspection of the company's Bioequivalence Center located at Taloja, Maharashtra from July 26-28, 2021, Alkem Laboratories said in a regulatory filing.
The reason public health officials are calling for more mask-wearing is that there is clear and mounting evidence that - though rare - breakthrough COVID-19 infections can occur in people who are fully vaccinated. This is particularly true with emerging variants of concern. The good news is that COVID-19 infection, if it does happen, is much less likely to lead to serious illness or death in vaccinated people.
According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decision to suspend the exceptional and temporary authorisation for import and distribution of Covaxin after Bharat Biotech informed the South America government about the termination of its pact with its Brazilian partners.
So why is RSV, considered a winter illness, peaking in the summer of 2021? Simply put, restrictions put in place for preventing the spread of COVID-19 held back other respiratory viruses too. As many countries are lifting these restrictions, many respiratory diseases are spreading again.
“It is a milestone achievement for both Biocon Biologics and our partner Viatris. This will allow pharmacy level substitution and thereby provide convenient and affordable access to Semglee, a quality Biosimilar Insulin Glargine,” Biocon Biologics, Executive Chairperson, Kiran Mazumdar-Shaw said in a statement.
During the second wave, Noccarc also worked with various large CSR organizations for deploying the ventilators in hospitals located at remote locations across the nation, a significant percentage of which were installed in government hospitals.
The change gives health providers more time to use remaining shots sitting at pharmacies, hospitals and clinics. After plateauing earlier this summer, vaccination rates have begun climbing again as the contagious delta variant surges across many parts of the country.
The subject expert committee (SEC) of Central Drugs Standards Control Organisation (CDSCO), however, told the company to conduct the trial first only on 100 children and then submit data to the drug regulator. "The trial will continue depending on the data on first 100 children," one of the sources said.
The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sandeep Rathod had earlier estimated a year to start making the vaccine.
The subject expert committee (SEC) of Central Drugs Standards Control Organisation (CDSCO), however, told the company to conduct the trial first only on 100 children and then submit data to the drug regulator. "The trial will continue depending on the data on first 100 children," one of the sources said.
At an informal meeting of heads of delegations last week, New Delhi said some members failed to engage in the text-based negotiation and also raised the issue of selective interpretation of rules and procedures during the negotiations.
Thierry Delaporte, MD and CEO at Wipro, told ET that he sees "significant potential" for growth in the US healthcare industry and is continuing to invest in growing its business in the sector. He added that healthcare was already among the best performing sectors for the company in the first quarter of the current fiscal.
"The scheme estimated the export generation potential of Rs 1,96,000 crore over a period of six years in all the three categories of products under the scheme, which includes high-value products as well," Chemicals and Fertilisers Minister Mansukh Mandaviya said in a written reply to the Lok Sabha.
After due deliberation, it has been decided that a dedicated window will be created on the National Career Service (NCS) portal of the ministry of labour and employment to match the demand for various categories of healthcare personnel and the available resources in a dynamic manner, the labour ministry said in an order dated July 26.
"I personally believe that unless we have treatments that are effective, we are not in a safe place. That is where we are coming from and we believe this is a very interesting opportunity for Biocon because it really allows us to expand into adjacent areas."
Different diseases have different thresholds for herd immunity. For measles, for example, the herd immunity threshold is 92%-94%. Estimates for COVID-19 have varied, with some putting it at 85% or higher. However, many hesitate to give a single number. Here are three reasons why.
TOI had reported on June 4 that private vaccination centres accounted for about 7.5% of vaccine doses administered since the beginning of the vaccination drive in January. The information given in Parliament shows that it remains at about the same level.
"Given the second wave of the pandemic that we had in India, we have seen pretty strong sales on Remdesivir: the product that we manufacture under licence from Gilead. That, of course, gave an additional boost in the quarter."
